表紙:ネブライザー:医療機器のパイプライン情勢 (2021年)
市場調査レポート
商品コード
995621

ネブライザー:医療機器のパイプライン情勢 (2021年)

Nebulizers - Medical Devices Pipeline Product Landscape, 2021

出版日: | 発行: GlobalData | ページ情報: 英文 50 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.22円
ネブライザー:医療機器のパイプライン情勢 (2021年)
出版日: 2021年03月10日
発行: GlobalData
ページ情報: 英文 50 Pages
納期: 即納可能 即納可能とは
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、ネブライザーのパイプライン情勢について詳細に調査分析し、開発のさまざまな段階における製品の比較分析および進行中の臨床試験に関する情報とともに、パイプライン製品に関する包括的な情報を提供しています。

目次

第1章 目次

第2章 イントロダクション

  • ネブライザーの概要

第3章 開発中の製品

  • ネブライザー:開発段階別のパイプライン製品
  • ネブライザー:セグメント別パイプライン製品
  • ネブライザー:地域別のパイプライン製品
  • ネブライザー:規制経路別のパイプライン製品
  • ネブライザー:承認予定日別のパイプライン製品
  • ネブライザー:進行中の臨床試験

第4章 ネブライザー:企業が開発中のパイプライン製品

  • ネブライザー企業:開発段階別のパイプライン製品
  • ネブライザー:開発段階別のパイプライン製品

第5章 ネブライザー企業と製品概要

  • Ablynx NV
  • Aeon Research & Technology
  • AFT Pharmaceuticals Ltd
  • Aura Medical
  • Baby's Breath Ltd.
  • Bridgesource Medical Corp
  • Creare LLC
  • DesignWise Medical Inc (Inactive)
  • HCmed Innovations Co Ltd
  • Marquette University
  • Parion Sciences Inc
  • RMIT University
  • SolAeroMed Inc
  • Stirling Pharma Inc
  • Teleflex Inc
  • University of California San Diego
  • University of Texas Medical Branch at Galveston
  • Verona Pharma Plc
  • Vincent Medical Holdings Ltd
  • Wellinks Inc

第6章 ネブライザー:近年の開発動向

第7章 付録

  • 調査手法
  • GlobalDataについて
  • お問い合わせ
  • 免責事項
図表

List of Tables

List of Tables

  • Nebulizers - Pipeline Products by Stage of Development
  • Nebulizers - Pipeline Products by Segment
  • Nebulizers - Pipeline Products by Territory
  • Nebulizers - Pipeline Products by Regulatory Path
  • Nebulizers - Pipeline Products by Estimated Approval Date
  • Nebulizers - Ongoing Clinical Trials
  • Nebulizers Companies - Pipeline Products by Stage of Development
  • Nebulizers - Pipeline Products by Stage of Development
  • Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview
  • Customised Infant Inhalation Device - Product Status
  • Customised Infant Inhalation Device - Product Description
  • Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • LYNX Nebulizer - Product Status
  • LYNX Nebulizer - Product Description
  • AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • NasoSURF - Product Status
  • NasoSURF - Product Description
  • AFT Pharmaceuticals Ltd - Ongoing Clinical Trials Overview
  • NasoSURF - A Single Center, Randomized, Controlled, Four Way Cross-over Clinical Study Investigating the Deposition of Aerosol Generated by the Nasal Mesh Nebulizer (NMN) Prototype into the Nasal Cavity Using Radio-labelled Saline at Different Pulse Frequency in Healthy Volunteers
  • Aura Medical Pipeline Products & Ongoing Clinical Trials Overview
  • Nebican - Product Status
  • Nebican - Product Description
  • Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • WiseAir - Product Status
  • WiseAir - Product Description
  • Bridgesource Medical Corp Pipeline Products & Ongoing Clinical Trials Overview
  • Breath-Adaptive Nebulizer - Product Status
  • Breath-Adaptive Nebulizer - Product Description
  • Creare LLC Pipeline Products & Ongoing Clinical Trials Overview
  • DDC-Based Nebulizer - Product Status
  • DDC-Based Nebulizer - Product Description
  • DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • Self-Contained Nebulizer System - Product Status
  • Self-Contained Nebulizer System - Product Description
  • HCmed Innovations Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • AdheResp - Product Status
  • AdheResp - Product Description
  • Marquette University Pipeline Products & Ongoing Clinical Trials Overview
  • Human Powered Nebulizer - Product Status
  • Human Powered Nebulizer - Product Description
  • Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
  • tPAD Device - Product Status
  • tPAD Device - Product Description
  • RMIT University Pipeline Products & Ongoing Clinical Trials Overview
  • UAS Nebulizer - Product Status
  • UAS Nebulizer - Product Description
  • SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview
  • S1226 Neublizer System - Product Status
  • S1226 Neublizer System - Product Description
  • Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
  • High Density Aerosol Drug Delivery Device - Product Status
  • High Density Aerosol Drug Delivery Device - Product Description
  • Teleflex Inc Pipeline Products & Ongoing Clinical Trials Overview
  • TURBOMIST - Product Status
  • TURBOMIST - Product Description
  • University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
  • Nebulizer - Product Status
  • Nebulizer - Product Description
  • University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • Pulse Drug Nebulization System - Product Status
  • Pulse Drug Nebulization System - Product Description
  • Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
  • RPL554 Nebulizer - Product Status
  • RPL554 Nebulizer - Product Description
  • Verona Pharma Plc - Ongoing Clinical Trials Overview
  • RPL554 Nebulizer - A Phase III Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine over 24 weeks (with a 48-week Safety Subset) in Subjects with Moderate to Severe COPD
  • RPL554 Nebulizer - A Phase III Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ensifentrine over 24 Weeks in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease
  • Vincent Medical Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Home Use Ultrasonic Nebulizer - Product Status
  • Home Use Ultrasonic Nebulizer - Product Description
  • Wellinks Inc Pipeline Products & Ongoing Clinical Trials Overview
  • Bluetooth Enabled Flyp Nebulizer - Product Status
  • Bluetooth Enabled Flyp Nebulizer - Product Description
  • Glossary

List of Figures

List of Figures

  • Nebulizers - Pipeline Products by Stage of Development
  • Nebulizers - Pipeline Products by Segment
  • Nebulizers - Pipeline Products by Territory
  • Nebulizers - Pipeline Products by Regulatory Path
  • Nebulizers - Pipeline Products by Estimated Approval Date
  • Nebulizers - Ongoing Clinical Trials
目次
Product Code: GDME1104EPD

GlobalData's Medical Devices sector report, "Nebulizers - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Nebulizers pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Nebulizer is a device which helps in direct delivery of medicine in case of respiratory disorders. It turns liquid medicine into mist (aerosol) to treat asthma, COPD, cystic fibrosis, and other respiratory disorders.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nebulizers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nebulizers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nebulizers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Nebulizers Overview

3 Products under Development

  • 3.1 Nebulizers - Pipeline Products by Stage of Development
  • 3.2 Nebulizers - Pipeline Products by Segment
  • 3.3 Nebulizers - Pipeline Products by Territory
  • 3.4 Nebulizers - Pipeline Products by Regulatory Path
  • 3.5 Nebulizers - Pipeline Products by Estimated Approval Date
  • 3.6 Nebulizers - Ongoing Clinical Trials

4 Nebulizers - Pipeline Products under Development by Companies

  • 4.1 Nebulizers Companies - Pipeline Products by Stage of Development
  • 4.2 Nebulizers - Pipeline Products by Stage of Development

5 Nebulizers Companies and Product Overview

  • 5.1 Ablynx NV Company Overview
  • 5.2 Aeon Research & Technology Company Overview
  • 5.3 AFT Pharmaceuticals Ltd Company Overview
  • 5.4 Aura Medical Company Overview
  • 5.5 Baby's Breath Ltd. Company Overview
  • 5.6 Bridgesource Medical Corp Company Overview
  • 5.7 Creare LLC Company Overview
  • 5.8 DesignWise Medical Inc (Inactive) Company Overview
  • 5.9 HCmed Innovations Co Ltd Company Overview
  • 5.10 Marquette University Company Overview
  • 5.11 Parion Sciences Inc Company Overview
  • 5.12 RMIT University Company Overview
  • 5.13 SolAeroMed Inc Company Overview
  • 5.14 Stirling Pharma Inc Company Overview
  • 5.15 Teleflex Inc Company Overview
  • 5.16 University of California San Diego Company Overview
  • 5.17 University of Texas Medical Branch at Galveston Company Overview
  • 5.18 Verona Pharma Plc Company Overview
  • 5.19 Vincent Medical Holdings Ltd Company Overview
  • 5.20 Wellinks Inc Company Overview

6 Nebulizers- Recent Developments

  • 6.1 Feb 17, 2021: U of M's Technological Leadership Institute names Professor Allison Hubel new director
  • 6.2 Feb 16, 2021: Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
  • 6.3 Feb 16, 2021: Owens & Minor will Report Fourth Quarter & Full Year Financial Results on Wednesday, February 24, 2021
  • 6.4 Feb 11, 2021: Teleflex Announces Fourth Quarter and Full Year 2020 Earnings Conference Call Information
  • 6.5 Feb 05, 2021: Cardinal Health Reports Second-Quarter Results for Fiscal Year 2021
  • 6.6 Feb 04, 2021: Cardinal Health Earnings Preview
  • 6.7 Jan 12, 2021: Vectura Group: Trading update
  • 6.8 Sep 09, 2020: AstraZeneca Alliance and NEBUCOR nebulizers subscribe for the benefit of asthma patients

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer